Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SRC | P12931 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CFTR | P13569 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aniline SCHEMBL9347211 | 0.90 | TSHR (0.41) | MEN1HTTKMT2ASRCCA2 | |
| SCHEMBL28255751 | 0.84 | MEN1 (0.42) | MEN1HTTKMT2ASRCCA2 | |
| SCHEMBL31297134 | 0.81 | CA2 (0.46) | MEN1HTTKMT2ASRCCA2 | |
| SCHEMBL28672425 | 0.78 | MEN1 (0.45) | MEN1HTTKMT2ASRCCA2 | |
| SCHEMBL2854023 | 0.78 | HTT (0.56) | MEN1HTTKMT2ASRCCA2 | |
| SCHEMBL11882378 | 0.77 | MEN1 (0.43) | MEN1HTTKMT2ASRCCA2 | |
| SCHEMBL29054216 | 0.76 | MEN1 (0.46) | MEN1HTTKMT2ACA2CA4 | |
| SCHEMBL2855667 | 0.74 | MEN1 (0.45) | MEN1HTTKMT2ASRCALDH1A1 | |
| SCHEMBL28485352 | 0.74 | MEN1 (0.41) | MEN1HTTKMT2ASRCCA2 | |
| SCHEMBL27552822 | 0.74 | MEN1 (0.41) | MEN1HTTKMT2ASRCCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024077650-A1 | SALT FORM OF COMPOUND HAVING SUBSTITUTED SULFONYLUREA RING AND CRYSTAL FORM THEREOF | 苏州二叶制药有限公司 | 2024-04-18 | — | — | WO | disclosed |
| CN-116507337-A | ATR inhibitors and uses thereof | 上海德琪医药科技有限公司 | 2023-07-28 | — | — | CN | disclosed |
| US-20230192691-A1 | HETEROCYCLIC COMPOUNDS AS BTK INHIBITORS | BEIJING INNOCARE PHARMA TECH CO LTD (CN) | 2023-06-22 | — | — | US | disclosed |
| CN-113975396-B | Pharmaceutical composition containing beta-lactam compound and application thereof | 中国医学科学院医药生物技术研究所 | 2022-11-29 | — | — | CN | disclosed |
| WO-2022037649-A1 | HETEROCYCLIC COMPOUNDS AS BTK INHIBITORS | BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) | 2022-02-24 | — | — | WO | disclosed |
| CN-113939300-A | STAT degradants and uses thereof | 凯麦拉医疗公司 | 2022-01-14 | — | — | CN | disclosed |
| CN-109826007-B | Halogen-free flame retardant emulsified dispersion liquid | 浙江工业职业技术学院 | 2021-09-03 | — | — | CN | disclosed |
| WO-2019141131-A1 | BROMODOMAIN INHIBITOR COMPOUND AND USE THEREOF | 中国科学院上海药物研究所 | 2019-07-25 | — | — | WO | disclosed |
| CN-105612166-A | Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration | MICURX PHARMACEUTICALS INC | 2016-05-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192691-A1 | HETEROCYCLIC COMPOUNDS AS BTK INHIBITORS | BTK, SYK, LYN | MEN1 785/4885HTT 1747/4885KMT2A 1636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.